Sputnik VVerified account

@sputnikvaccine

Sputnik V is the world’s first registered COVID-19 vaccine with over 91.6% efficacy, developed by Gamaleya Inst. Authorized in 71 countries.

Moscow, Russia
sputnikvaccine.com
Joined August 2020
872 Photos and videos Photos and videos

Tweets

You blocked @sputnikvaccine

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @sputnikvaccine

  1. Pinned Tweet
    Jan 20

    1/5 BREAKING: shows strong protection against , over 2x higher virus neutralizing activity vs Pfizer vaccine, in independent study by EU-based Spallanzani Institute . READ👇

    366 replies 2,710 retweets 17,159 likes
    Show this thread
    Show this thread
    Undo
  2. 12 hours ago

    The Wall Street Journal: “What to Know About the BA.2 Omicron Variant, the New Covid Strain. At least 40 countries including the U.S., U.K., India and Denmark have detected the version of the virus”👇

    2 replies 18 retweets 36 likes
    Undo
  3. 18 hours ago

    The Daily Mail: “Hospitalised Covid patients should also be tested for flu as having both 'doubles the risk of dying', say researchers”👇

    4 replies 30 retweets 77 likes
    Undo
  4. Mar 25

    Fortune: “Stealth Omicron now makes up most global COVID cases. WHO officials say Feb 16-Mar 17 BA.2 made up 86% of reported cases, huge jump from the last report made on Mar 8 when BA.2 made up just 34% of new cases.” 👇

    4 replies 16 retweets 38 likes
    Undo
  5. Mar 25

    FT: “European wave of Omicron sub-variant BA.2 foreshadows US surge. North America is likely to be hit by a sharp rise in infections within weeks, experts warn” 👇

    11 retweets 36 likes
    Undo
  6. Mar 24

    CNN: “European countries now battling Covid BA.2 variant lifted restrictions too 'brutally,' WHO warns” 👇

    5 replies 28 retweets 67 likes
    Undo
  7. Mar 24

    The Star: “ conditions can occur in 15-30% of patients who have recovered, with symptoms lasting from 4 to 12 weeks after infection, says Dr Prasit Watanapa, Dean of the Faculty of Medicine, Siriraj Hospital in Thailand” 👇

    3 replies 6 retweets 45 likes
    Undo
  8. Mar 24

    The Guardian: “ Covid could create a generation affected by disability, with people forced out of their homes and work, and some even driven to suicide, says Professor Danny Altmann, immunologist at Imperial College London” 👇

    3 replies 20 retweets 34 likes
    Undo
  9. Mar 23

    CNBC: “Omicron's 'stealth' subvariant BA.2 could go 'wild' in Europe before going global, top epidemiologist says” 👇

    2 replies 24 retweets 71 likes
    Undo
  10. Mar 23

    WSJ: “Large new study found that people recovered from COVID within past year are 40% more likely to get diabetes compared to those who weren’t infected. may result in millions of new diabetes cases world-wide” 👇

    2 replies 25 retweets 44 likes
    Undo
  11. Mar 23

    WSJ: “ BA.2 variant represents rising share of U.S. COVID cases. CDC data released Tuesday put BA.2 at about 35% of U.S. cases as of the week ending on March 19” 👇

    2 replies 14 retweets 41 likes
    Undo
  12. Mar 22

    Study from University of Cambridge demonstrated that “many patients are experiencing significant memory or concentration impairments even after mild illness. More than ½ were unable to work for extended periods, 1/3 lost jobs due to illness” 👇

    1 reply 18 retweets 39 likes
    Undo
  13. Mar 22

    France 24: “COVID-19 is again surging in Western Europe due to a "perfect storm" of governments lifting restrictions, waning immunity & more contagious BA.2 Omicron subvariant. UK, France, Germany & Italy have all seen dramatic resurgence of infections” 👇

    1 reply 10 retweets 27 likes
    Undo
  14. Mar 22

    Bloomberg: “COVID tests show BA.2 subvariant is gaining ground in U.S. A San Diego-based genomics firm estimates that 50% to 70% of all COVID cases nationwide are BA.2” 👇

    1 reply 11 retweets 31 likes
    Undo
  15. Mar 22

    Hetero, Sputnik’s partner in India, becomes 1st Indian company to receive license to produce&market 1-shot Sputnik Light, effective standalone vaccine & universal booster for other jabs. Sputnik Light works against /other mutations. 👇

    3 replies 26 retweets 62 likes
    Undo
  16. Mar 21

    Study in Nature points out that SARS-CoV-2 unique ability for recombination (genetic info exchange occurring when at least 2 viral genomes co-infect same host cell) leads to constant emergence of new variants. 👇

    2 replies 19 retweets 46 likes
    Undo
  17. Mar 21

    CNBC: “Health experts predict uptick in U.S. COVID cases due to new BA.2 variant, which is already estimated to account for about 25% or 30% of new cases in the U.S.” 👇

    1 reply 21 retweets 44 likes
    Undo
  18. Mar 21

    UPI: “Some nations in Europe, including Italy with a 43% rise in new COVID cases and France with 36% rise in new cases, have experienced surges as a new SARS-COV-2 sub-variant travels around the world” 👇

    19 retweets 44 likes
    Undo
  19. Mar 20

    NYT: “The clearest warning that brief period of quiet may soon be over came from Western Europe. In a number of countries, including UK, France & Germany, case numbers are climbing as more contagious subvariant of , known as BA.2, takes hold” 👇

    2 replies 15 retweets 47 likes
    Undo
  20. Mar 20

    A. Gintsburg, the Gamaleya Center head, on Sputnik nasal vaccine: “It has been tested against variant and it works” The Gamaleya Center submitted the documents for the nasal form of Sputnik vaccine authorization to the Health Ministry. Authorization is expected shortly

    15 replies 98 retweets 286 likes
    Undo
  21. Mar 19

    NBC New York: "Stealth COVID Variant Spreading Faster in NY Than US." According to the CDC, the "stealth" omicron variant, BA.2, accounts for 39% of COVID circulating in New York. 👇

    12 replies 20 retweets 48 likes
    Undo

@sputnikvaccine hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·